News

In the latest lawsuit, an Idaho woman, who was hospitalized and had to have her gallbladder removed, alleges that the drug manufacturer was negligent and fraudulently misrepresented the drug's gastrointestinal issues.

"Many employers are unaware — or are surprised to learn — the realities of what their employees experience when it comes to workplace safety and mental health," Mike Dahir, Traliant's CEO, said.

The conglomerate announced its plan to halt pensions for non-union workers, shortly after IBM's announcement to resurrect DB plans, while other firms might need to reassess their own retirement strategies to assure an optimal fit.

Launched after the Supreme Court rejected President Biden's sweeping $10,000 loan forgiveness plan last summer, the SAVE program for those who borrowed less than $12,000, is set to begin in February, months ahead of schedule.

With the price of GLP-1s reaching well over $1000 a month, local officials are warning that rising costs threaten to quickly drain government spending accounts.

The Value in Health Care Act would provide a 2-year extension of the 5% advanced payment model incentives, which allow clinicians to cover some of the costs of moving to a new payment model, including expanding care teams.

Alex Azar, former Health and Human Services secretary who approved of drug importation, is now chairman of the board of LifeScience Logistics, which is managing Florida's $39 million Canadian drug importation program.

The former South Carolina governor, who's now vying to be president, has become well known as one of the ACA's loudest critics, and is making her views known on abortion, vaccine mandates and other health care topics.